Johnson & Johnson HALTS Production of SINGLE-DOSE VACCINE

https://www-cbsnews-com.cdn.ampproject.org/v/s/www.cbsnews.com/amp/news/johnson-johnson-covid-19-vaccine-production-halt/?amp_gsa=1&amp_js_v=a8&usqp=mq331AQIKAGwASCAAgM=#app

This is not due to any problem with the Jansen/ J&J vaccine. It was an issue of profitability and research facility capacity.

There had only been one of their labs, in the Netherlands, producing their vaccine, which they quietly stopped doing, recently. They are now using the facility to research what would be a more profitable drug; they intend to re-start production of their single-dose vaccine at some point, but an exact date has not yet been determined (or at least not shared, by J & J).

[SNIP]:

Drugmaker Johnson & Johnson has halted production of its single-dose COVID-19 vaccine, according to a New York Times report.

The pharmaceutical company last year quietly shut down production at a plant in Leiden, Netherlands, which was the only facility where usable doses of the vaccine were manufactured, catching some of its customers off guard, including developing nations that prefer the single-dose J&J drug over two-dose alternatives, the report states.

Johnson & Johnson has instead been using the plant to work on an experimental and potentially more profitable drug that could protect against an unrelated respiratory virus, according to the report.

The plant is expected to resume manufacturing of the COVID-19 vaccine, but it is unclear when.

J&J did not comment on the plant closure reports, but said in a statement to CBS News "we currently have millions of doses of our COVID-19 vaccine in inventory" and "we continue to fulfill our contractual obligations ... [to] the African Union."

[END SNIP]

The article adds that the Jansen vaccine has been the choice for the world's poorer nations, and that the wealthier ones have had a preference for the Pfizer & Moderna vaccines, because of a rare but potentially life-threatening blood-clotting side-effect, that's been linked to the J & J vaccine.